Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ABLD.PAthis companyABL Texcell Diagnostics S.A.	€2.40	-3.55×	0.19×	0×	-7.44×	329.5%	0.0%	0.0%	0.0%	-5.4%	-3.9%	-11.4%	0×	-9.13×	-9,331.09×	28.79×	0.0%	3	230.99	—	—
ABNX.PAABIONYX Pharma S.A.	€1.66	-23.69×	31.58×	33.12×	-23.64×	-400.0%	9.3%	-154.0%	-136.6%	-130.3%	-65.5%	-2.4%	0.89×	-0.05×	-31.28×	1.06×	0.0%	2	2.27	1	D+
ALBKK.PABaikowski S.A.	€19.20	22.94×	1.86×	1.69×	10.92×	0.9%	24.2%	5.9%	7.4%	8.1%	3.9%	1.3%	0.36×	0.98×	8.26×	2.09×	1.3%	5	2.69	3	B
ALDVI.PAAdvicenne S.A.	€0.65	-2.4×	-0.87×	3.81×	-5.2×	-2880.5%	-15.4%	-139.1%	-158.7%	36.2%	132.8%	-17.9%	-0.72×	-2.26×	-5.43×	0.48×	0.0%	3	-4.89	1	C-
ALNSE.PANSE S.A.	€36.60	22.92×	2.49×	1.11×	11.76×	-158.4%	49.0%	8.6%	4.9%	10.9%	8.3%	2.6%	0.64×	1.31×	13.2×	1.8×	0.7%	6	1.2	4	A-
ALPJT.PAPoujoulat S.A.	€5.84	-15.02×	0.47×	0.17×	13.82×	-56.1%	12.1%	-0.8%	-1.1%	-3.1%	-0.7%	8.9%	0.97×	9.08×	-0.7×	1.56×	1.5%	3	1.39	2	C
Peer median	—	-2.4×	1.86×	1.69×	10.92×	-158.4%	12.1%	-0.8%	-1.1%	8.1%	3.9%	1.3%	0.64×	0.98×	-0.7×	1.56×	0.7%	3	1.39	2	—